Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.13 | 0.6 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |